Moderna’s Stock is Up 20-fold Since the End of 2019 After the Success of Its MRNA ... - Latest Tweet by Reuters

Moderna’s stock is up 20-fold since the end of 2019 after the success of its mRNA vaccine. Long-term plans are starting to fill the gap once COVID-related demand subsides. From @Breakingviews: https://t.co/fY6siraoVG https://t.co/fY6siraoVG— Reuters (@Reuters) August 6, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)